Thursday 8th April 2020 GatewayC have produced a list of cancer charity support lines; for patients who may be worried about their cancer diagnosis or concerned how coronavirus may affect their cancer treatment. Please download this PDF resource or find the list of...
Updated resource: unpicking the COVID-19 extremely vulnerable category for people affected by cancer
Latest from the Blog
Cancer Keys: COVID-19 and Neutropenic Sepsis
Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...
Related Posts
MGUS and Myeloma: What’s the link?
MGUS is a benign condition which does not usually require treatment. However, a small number of patients diagnosed with MGUS will go on to develop myeloma. Understanding MGUS Monoclonal gammopathy of undetermined significance (MGUS) is a benign condition characterised...
You, Me and GatewayC… An interview with Lauren Mahon and Deborah James
11 January 2019 GatewayC is an online cancer education platform for primary care. It is designed to support GPs with earlier cancer detection to improve outcomes and experiences for patients. GatewayC works with people affected by cancer to understand how to better...

Wednesday 15th April 2020
People with certain cancers and those who have received or are receiving certain treatments are at risk of severe illness if they catch coronavirus (COVID-19). One Cancer Voice charities (in partnership with NHS England) have confirmed this includes:
- Every patient undergoing active chemotherapy
- Patients who have received chemotherapy in the last three months (advise patients to contact their care team to discuss their specific circumstances. In the meantime, patients should follow the Public Health England guidance on ‘shielding’ – in summary, stay at home and avoid face-to-face contact for a period of 12 weeks)
- Patients with blood disorders who are immunocompromised but not receiving chemotherapy
- Patients having radiotherapy for metastatic lung tumours
- Patients with metastatic cancer in the lungs who are not currently receiving treatment (if they have not received a letter, advise patients to contact their care team to discuss their specific circumstances. In the meantime, patients should follow the Public Health England guidance on ‘shielding’ – in summary, stay at home and avoid face-to-face contact for a period of 12 weeks)
- Patients having any targeted treatments (more than just antibody treatments) and anti-angiogenesis targeted drugs
- Transplant patients (if they have had a transplant within the last 6 months, and if they are taking any immunosuppression)
- Patients with a rare disease and that disease significantly increases their risk of infection
Find out more:
- Read the latest charity guidance
- Read the latest government guidance

Latest from the Blog
Resource: charity support lines for patients living with cancer
Thursday 8th April 2020 GatewayC have produced a list of cancer charity support lines; for patients who may be worried about their cancer diagnosis or concerned how coronavirus may affect their cancer treatment. Please download this PDF resource or find the list of...
Cancer Keys: COVID-19 and Neutropenic Sepsis
Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...
Related Posts
MGUS and Myeloma: What’s the link?
MGUS is a benign condition which does not usually require treatment. However, a small number of patients diagnosed with MGUS will go on to develop myeloma. Understanding MGUS Monoclonal gammopathy of undetermined significance (MGUS) is a benign condition characterised...
You, Me and GatewayC… An interview with Lauren Mahon and Deborah James
11 January 2019 GatewayC is an online cancer education platform for primary care. It is designed to support GPs with earlier cancer detection to improve outcomes and experiences for patients. GatewayC works with people affected by cancer to understand how to better...